Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Changsha Huir Biological-Tech Co., Ltd. is a high-tech multinational corporation founded in 2006 and headquartered in Changsha, China. The company specializes in the research, development, and manufacturing of high-quality health ingredients, including botanical extracts, nutraceuticals, and active pharmaceutical ingredients (APIs). Huir operates as a vertically integrated entity with five manufacturing plants in China and distribution centers in the United States and Europe. Its product portfolio features key ingredients such as Resveratrol, Huperzine A, Milk Thistle extract, and L-Glutathione, serving the nutrition, food and beverage, and cosmetic industries. The company is certified by CGMP, ISO, and other international standards, positioning itself as a global supplier in the health and wellness market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Changsha Huir.